H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias-Reference-Cited by-同舟云学术

H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias

Published:2008-11 Issue:5 Volume:14 Page:355-368
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Krivtsov Andrei V.,Feng Zhaohui,Lemieux Madeleine E.,Faber Joerg,Vempati Sridhar,Sinha Amit U.,Xia Xiaobo,Jesneck Jonathan,Bracken Adrian P.,Silverman Lewis B.,Kutok Jeffery L.,Kung Andrew L.,Armstrong Scott A.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference38 articles.

1. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia;Armstrong;Nat. Genet.,2002

2. Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification;Armstrong;Cancer Cell,2003

3. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins;Ayton;Oncogene,2001

4. Biological and therapeutic aspects of infant leukemia;Biondi;Blood,2000

5. The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling;Bitoun;Hum. Mol. Genet.,2007

Cited by 475 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Novel Non-nucleoside DOT1L^R231Q Inhibitors with Improved Pharmacokinetic Properties and Anti-lung Cancer Efficacy;Journal of Medicinal Chemistry;2024-09-10

2. Discovery of first-in-class DOT1L inhibitors against the R231Q gain-of-function mutation in the catalytic domain with therapeutic potential of lung cancer;Acta Pharmaceutica Sinica B;2024-08

3. Therapeutic Targeting of the Menin–KMT2A Interaction;Annual Review of Cancer Biology;2024-06-12

4. Chromatin and aberrant enhancer activity in KMT2A rearranged acute lymphoblastic leukemia;Current Opinion in Genetics & Development;2024-06

5. Distinct Responses to Menin Inhibition and Synergy with DOT1L Inhibition in KMT2A-Rearranged Acute Lymphoblastic and Myeloid Leukemia;International Journal of Molecular Sciences;2024-05-30